REDWOOD CITY, Calif. - Soleno Therapeutics, Inc. (NASDAQ:SLNO), whose stock has surged 116% over the past year and is trading near its 52-week high of $85.36, presented new data on VYKAT XR ...

About PWS Prader-Willi syndrome (PWS) is a rare genetic neurodevelopmental disorder caused by an abnormality in the gene expression on chromosome 15.

Soleno Therapeutics will present research on Prader-Willi syndrome at the upcoming International PWS Conference in Phoenix, AZ.

About PWSPrader-Willi syndrome (PWS) is a rare genetic neurodevelopmental disorder caused by an abnormality in the gene expression on chromosome 15. The Prader-Willi Syndrome Association USA ...

Conference is the first-ever international meeting jointly hosted by the Prader-Willi Syndrome Association | USA, the Foundation for Prader-Willi Research, and the International Prader-Willi ...

SAN DIEGO, June 24, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule ...

Michigan mom shares daughter's journey with Prader-Willi syndrome A mother in Michigan hopes a wheelchair-accessible van will provide freedom and ease for her daughter with Prader-Willi syndrome.

Prader-Willi syndrome (PWS) is a rare genetic neurodevelopmental disorder caused by an abnormality in the gene expression on chromosome 15. The Prader-Willi Syndrome Association USA estimates that PWS ...

Four years before Kimberly Gallagher enrolled in Medicaid herself, the public health insurance program's rules prompted her ...

Prader-Willi syndrome (PWS) is a rare genetic neurodevelopmental disorder caused by an abnormality in the gene expression on chromosome 15. The Prader-Willi Syndrome Association | USA estimates that ...

About PWS Prader-Willi syndrome (PWS) is a rare genetic neurodevelopmental disorder caused by an abnormality in the gene expression on chromosome 15.